Cargando…

Serological Markers of SARS-CoV-2 Reinfection

As public health guidelines throughout the world have relaxed in response to vaccination campaigns against SARS-CoV-2, it is likely that SARS-CoV-2 will remain endemic, fueled by the rise of more infectious SARS-CoV-2 variants. Moreover, in the setting of waning natural and vaccine immunity, reinfec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siddiqui, Sameed M., Bowman, Kathryn A., Zhu, Alex L., Fischinger, Stephanie, Beger, Samuel, Maron, Jenny S., Bartsch, Yannic C., Atyeo, Caroline, Gorman, Matthew J., Yanis, Ahmad, Hultquist, Judd F., Lorenzo-Redondo, Ramon, Ozer, Egon A., Simons, Lacy M., Talj, Rana, Rankin, Danielle A., Chapman, Lindsay, Meade, Kyle, Steinhart, Jordan, Mullane, Sean, Siebert, Suzanne, Streeck, Hendrik, Sabeti, Pardis, Halasa, Natasha, Musk, Elon R., Barouch, Dan H., Menon, Anil S., Nilles, Eric J., Lauffenburger, Douglas A., Alter, Galit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787477/ https://www.ncbi.nlm.nih.gov/pubmed/35073738 http://dx.doi.org/10.1128/mbio.02141-21

Ejemplares similares

SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort
por: Finch, Emilie, et al.
Publicado: (2022)

Discrete SARS-CoV-2 antibody titers track with functional humoral stability
por: Bartsch, Yannic C., et al.
Publicado: (2021)

Epidemiological and immunological features of obesity and SARS-CoV-2
por: Nilles, Eric J, et al.
Publicado: (2020)

Epidemiological and Immunological Features of Obesity and SARS-CoV-2
por: Nilles, Eric J., et al.
Publicado: (2021)

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
por: Loos, Carolin, et al.
Publicado: (2020)

Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles
por: Kaplonek, Paulina, et al.
Publicado: (2021)

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
por: Kaplonek, Paulina, et al.
Publicado: (2022)

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
por: Kaplonek, Paulina, et al.
Publicado: (2022)

Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19
por: Kaplonek, Paulina, et al.
Publicado: (2021)

Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
por: Zohar, Tomer, et al.
Publicado: (2020)

Sex differences in vaccine-induced humoral immunity
por: Fischinger, Stephanie, et al.
Publicado: (2018)

A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis
por: Fischinger, Stephanie, et al.
Publicado: (2021)

110 Clinical Presentations of Adult and Pediatric SARS-CoV-2-Positive Cases in a Community Cohort
por: Rankin, Danielle A, et al.
Publicado: (2022)

An Integrated Brain-Machine Interface Platform With Thousands of Channels
por: Musk, Elon
Publicado: (2019)

488. Comparison of Demographics and Clinical Characteristics of Multisystem Inflammatory Syndrome in Children and Kawasaki Disease
por: Talj, Rana, et al.
Publicado: (2021)

Respiratory pathogens during the COVID-19 pandemic: Alterations in detection and seasonality in Nashville, Tennessee
por: Haddadin, Zaid, et al.
Publicado: (2022)

568. Comparison of Humoral Immune Response to the SARS-CoV-2 BNT162b2 Vaccine Between Solid Organ Transplant Recipients and Healthy Controls
por: Yanis, Ahmad, et al.
Publicado: (2021)

COVID-19 reinfection: prolonged shedding or true reinfection?
por: Falahi, S., et al.
Publicado: (2020)

58. Clinical Characteristics of SARS-CoV-2 Among Confirmed and Suspected Cases in Tennessee
por: Talj, Rana, et al.
Publicado: (2020)

290. Persistence of Long COVID in SARS-CoV-2 Confirmed Cases One-Year Post Infection
por: Howe, Harrison L, et al.
Publicado: (2021)

A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation()
por: Fischinger, Stephanie, et al.
Publicado: (2019)

SARS-CoV-2-specific ELISA development
por: Roy, Vicky, et al.
Publicado: (2020)

581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee
por: Fernandez, Kailee N, et al.
Publicado: (2021)

Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy
por: Bartsch, Yannic C., et al.
Publicado: (2022)

A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection
por: Malherbe, Delphine C., et al.
Publicado: (2022)

T cell and antibody functional correlates of severe COVID-19
por: Yu, Krystle K.Q., et al.
Publicado: (2020)

Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2
por: Yu, Krystle K.Q., et al.
Publicado: (2021)

Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection
por: Pullen, Krista M., et al.
Publicado: (2021)

Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination
por: Roy, Vicky, et al.
Publicado: (2023)

Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2
por: Nilles, Eric J., et al.
Publicado: (2020)

Detect and destroy: CRISPR-based technologies for the response against viruses
por: Freije, Catherine A., et al.
Publicado: (2021)

Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study
por: Turbett, Sarah E, et al.
Publicado: (2022)

480. Outbreak of COVID-19 Among School Auction Attendees: Was it a “Silent Auction” or “Silent Transmission”?
por: Rankin, Danielle A, et al.
Publicado: (2020)

Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
por: Atyeo, Caroline, et al.
Publicado: (2020)

COVID-19 reinfection after pregnancy
por: Gobin, L., et al.
Publicado: (2022)

IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees
por: Fischinger, Stephanie, et al.
Publicado: (2020)

COVID-19 Reinfection
por: Habadi, Mohammed I, et al.
Publicado: (2021)

The Antibodiome—Mapping the Humoral Immune Response to HIV
por: Butler, Audrey L., et al.
Publicado: (2019)

The impact of community closures among nonessential and essential workers, Nashville, Tennessee: A cross‐sectional study
por: Rankin, Danielle A., et al.
Publicado: (2022)

Clinical presentations of adult and pediatric SARS‐CoV‐2‐positive cases in a community cohort, Nashville, Tennessee
por: Rankin, Danielle A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qif8daho0rbnogh25gkhvdt302